PHASE-I PHASE-II PREVENTIVE VACCINE TRIALS - CONFERENCE SUMMARY

被引：12

作者：

WALKER, MC

FAST, PE

GRAHAM, BS

BELSHE, R

DOLIN, R

机构：

[1] NIAID,DIV AIDS,CLIN DEV BRANCH,BETHESDA,MD 20892

[2] VANDERBILT UNIV,SCH MED,DEPT MED,NASHVILLE,TN 37232

[3] VANDERBILT UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,NASHVILLE,TN 37232

[4] ST LOUIS UNIV,SCH MED,DEPT MED,ST LOUIS,MO 63110

[5] UNIV ROCHESTER,MED CTR,DEPT MED,ROCHESTER,NY 14642

来源：

AIDS RESEARCH AND HUMAN RETROVIRUSES | 1995年 / 11卷 / 10期

关键词：

D O I：

10.1089/aid.1995.11.1279

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1279 / 1285

页数：7

共 29 条

[1] NEUTRALIZING ANTIBODIES TO HIV-1 IN SERONEGATIVE VOLUNTEERS IMMUNIZED WITH RECOMBINANT GP120 FROM THE MN STRAIN OF HIV-1 [J].

BELSHE, RB ;

GRAHAM, BS ;

KEEFER, MC ;

GORSE, GJ ;

WRIGHT, P ;

DOLIN, R ;

MATTHEWS, T ;

WEINHOLD, K ;

BOLOGNESI, DP ;

SPOSTO, R ;

STABLEIN, DM ;

TWADDELL, T ;

BERMAN, PW ;

GREGORY, T ;

IZU, AE ;

WALKER, MC ;

FAST, P .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (06) :475-480

[2]

BELSHE RB, 1994, JAMA-J AM MED ASSOC, V272, P431, DOI 10.1001/jama.272.6.431b

[3] SAFETY AND IMMUNOGENICITY OF A FULLY GLYCOSYLATED RECOMBINANT GP160 HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VACCINE IN SUBJECTS AT LOW-RISK OF INFECTION [J].

BELSHE, RB ;

CLEMENTS, ML ;

DOLIN, R ;

GRAHAM, BS ;

MCELRATH, J ;

GORSE, GJ ;

SCHWARTZ, D ;

KEEFER, MC ;

WRIGHT, P ;

COREY, L ;

BOLOGNESI, DP ;

MATTHEWS, TJ ;

STABLEIN, DM ;

OBRIEN, FS ;

EIBL, M ;

DORNER, F ;

KOFF, W .

JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (06) :1387-1395

[4] IMMUNIZATION WITH SUBUNIT HUMAN-IMMUNODEFICIENCY-VIRUS VACCINE GENERATES STRONGER T-HELPER CELL-IMMUNITY THAN NATURAL INFECTION [J].

CLERICI, M ;

TACKET, CO ;

VIA, CS ;

LUCEY, DR ;

MULUK, SC ;

ZAJAC, RA ;

BOSWELL, RN ;

BERZOFSKY, JA ;

SHEARER, GM .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (06) :1345-1349

[5] ENHANCED IMMUNITY TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ENVELOPE ELICITED BY A COMBINED VACCINE REGIMEN CONSISTING OF PRIMING WITH A VACCINIA RECOMBINANT EXPRESSING HIV ENVELOPE AND BOOSTING WITH GP160-PROTEIN [J].

COONEY, EL ;

MCELRATH, MJ ;

COREY, L ;

HU, SL ;

COLLIER, AC ;

ARDITTI, D ;

HOFFMAN, M ;

COOMBS, RW ;

SMITH, GE ;

GREENBERG, PD .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) :1882-1886

[6] SAFETY OF AND IMMUNOLOGICAL RESPONSE TO A RECOMBINANT VACCINIA VIRUS-VACCINE EXPRESSING HIV ENVELOPE GLYCOPROTEIN [J].

COONEY, EL ;

COLLIER, AC ;

GREENBERG, PD ;

COOMBS, RW ;

ZARLING, J ;

ARDITTI, DE ;

HOFFMAN, MC ;

HU, SL ;

COREY, L .

LANCET, 1991, 337 (8741) :567-572

[7] THE SAFETY AND IMMUNOGENICITY OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RECOMBINANT GP160 CANDIDATE VACCINE IN HUMANS [J].

DOLIN, R ;

GRAHAM, BS ;

GREENBERG, SB ;

TACKET, CO ;

BELSHE, RB ;

MIDTHUN, K ;

CLEMENTS, ML ;

GORSE, GJ ;

HORGAN, BW ;

ATMAR, RL ;

KARZON, DT ;

BONNEZ, W ;

FERNIE, BF ;

MONTEFIORI, DC ;

STABLEIN, DM ;

SMITH, GE ;

KOFF, WC .

ANNALS OF INTERNAL MEDICINE, 1991, 114 (02) :119-127

[8]

ELDAHER N, 1993, J INFECT DIS, V168, P306, DOI 10.1093/infdis/168.2.306

[9]

GORSE GJ, 1994, CLIN EXP IMMUNOL, V98, P178

[10] LYMPHOCYTE PROLIFERATIVE RESPONSES FOLLOWING IMMUNIZATION WITH HUMAN-IMMUNODEFICIENCY-VIRUS RECOMBINANT GP160 [J].

GORSE, GJ ;

BELSHE, RB ;

NEWMAN, FK ;

FREY, SE .

VACCINE, 1992, 10 (06) :383-388

← 1 2 3 →